Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CVTVT

Financiado

Cerrado

A Non Surgical Treatment to Restore Heart Valve Function

"CroíValve is an innovative SME with the mission to lead the treatment of tricuspid valve disease and transform the lives of patients who currently face certain death. In the US and EU, 550,000 patients present with tricuspid va... ver más

31/10/2022

CROIVALVE

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

CROIVALVE LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-10-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 46% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

CROIVALVE

2.49M€ | Lider

TALLERES ELKORO

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TriSol System A heart valve prosthesis and delivery system intended to rep... 71K€ Cerrado

Trillium A transcatheter functional valve replacement for tricuspid v... 6M€ Cerrado

Trisol System A safe and effective replacement valve for treating severe T... 3M€ Cerrado

Duo Duo A minimally invasive device to treat all patients with... 4M€ Cerrado

TRICARIX Minimally invasive transcatheter system for tricuspid heart... 4M€ Cerrado

TRIFLO One Valve For Life The First Durable Non Thrombotic Heart V... 4M€ Cerrado

Duración del proyecto: 38 meses Fecha Inicio: 2019-08-20
Fecha Fin: 2022-10-31

Líder del proyecto

CROIVALVE LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 5M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "CroíValve is an innovative SME with the mission to lead the treatment of tricuspid valve disease and transform the lives of patients who currently face certain death. In the US and EU, 550,000 patients present with tricuspid valve disease annually. Current treatment involves highly invasive, risky open-heart surgery and <1% receive this due to the risks involved. Recent clinical data is highlighting that the ""forgotten tricuspid valve"" must be treated. CroíValve has developed a non-invasive device uniquely tailored to the challenges of the tricuspid valve. It is a small device that is delivered through a vein into the right heart, restoring the function of the tricuspid valve. Invented by a leading cardiologist, and refined by expert biomedical engineers, CroíValve’s is a non-surgical, safe, effective, easy to use solution for treating all patients with TR. It will transform patients’ lives, provide physicians a safe and straightforward treatment option and reduce the hospitalisations. There is a significant market potential of > €2.5Bn/year. With H2020 SMEi funding, this Phase 2 Innovation Proposal will support the activities necessary to complete clinical trials and demonstrate safety and efficacy for CE Mark approval. Securing this grant, alongside private funding, will enable the company to expand its manufacturing capabilities, build up its sales and marketing infrastructure. CroíValve’s management team have a successful track record in the development, patenting and commercialisation of medical devices who can position the company as a leader in the treatment of tricuspid valve disease."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores